Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2025
Kneat reported record Q4 2025 revenue of $17.0 million, a 24% increase year‑over‑year, and total 2025 revenue of $63.3 million, up 29%. SaaS sales surged 29% in the quarter and 33% for the full year, pushing annual recurring revenue to $74.1 million. Adjusted EBITDA turned positive for the second straight year, reaching $9.5 million, while net loss narrowed to $2.3 million. The company also earned top G2 rankings and announced strategic AI enhancements and a partnership with Capgemini.
DIRTT Reports Fourth Quarter 2025 Financial Results and Provides 2026 Guidance
DIRTT Environmental Solutions reported fourth‑quarter 2025 revenue of $50.9 million, a 4 % year‑over‑year increase, and adjusted EBITDA of $6.2 million, aligning with its guidance range. The quarter posted a net loss of $3.7 million after one‑time lease impairment and higher reorganization costs, while...
Stantec Reports Record 2025 Results, Achieves 17.6% Adjusted EBITDA Margin, Increases Dividend by 8.9%, and Provides 2026 Outlook
Stantec posted record 2025 results, delivering $6.5 billion in net revenue, a 10.7% year‑over‑year increase, and an adjusted EBITDA of $1.14 billion, lifting its margin to a record 17.6%. Diluted earnings per share rose 19.9% to $4.20, while operating cash flow jumped...
Exosens Exceeds 2025 Guidance, Driven by Strong Defense Momentum in Night Vision and Digital Imaging; New Mid-Term Outlook: Accelerating Our...
Exosens reported 2025 results that beat its guidance, posting €468.2 m revenue, a 22% year‑on‑year increase, and net profit that more than doubled to €42.7 m. Growth was powered by a surge in Defense night‑vision sales, highlighted by a €500 m contract with...
EuroDry Ltd. Sets Date for the Release of Fourth Quarter 2025 Results, Conference Call and Webcast
EuroDry Ltd. announced that it will publish its fourth‑quarter 2025 financial results on Thursday, February 19, 2026, after the New York market closes. The release will be accompanied by a conference call and a live webcast for analysts and investors....
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
Prenetics announced FY 2025 revenue of $92.4 million, a 480% YoY increase, driven by its IM8 brand which reached $120 million in annualized recurring revenue within its first year. Q4 revenue rose 55% sequentially to $36.6 million, while the company completed divestitures of ACT Genomics,...
Aware Sets Fourth Quarter and Full Year 2025 Webcast for Wednesday, March 4, 2026, at 5:00 P.m. Eastern Time
Aware, Inc. announced a webcast on March 4, 2026 at 5 p.m. Eastern to present its fourth‑quarter and full‑year 2025 financial results. The company will release the earnings press release prior to the call and host a live Q&A session. Aware highlighted that...
LGI Homes, Inc. Reports Fourth Quarter and Full Year 2025 Results and Issues Guidance for 2026
LGI Homes posted a strong fourth‑quarter 2025, generating $1.2 billion in revenue, an 8% year‑over‑year increase, and delivering 7,500 homes. Full‑year 2025 results showed $4.6 billion in revenue and a record net income of $450 million. The company issued 2026 guidance forecasting $4.9 billion...
Seanergy Maritime Reports Strong Fourth Quarter and Full-Year 2025 Results
Declares $0.20 Per Share Dividend and Expands Prompt Newbuilding Program Totaling $226m
SEALSQ Announces FY 2025 Key Preliminary / Unaudited Financials Metrics: Reports 66% Year Over Year Revenue Growth to $18 Million
SEALSQ Corp reported FY 2025 revenue of $18 million, a 66% year‑over‑year increase, while maintaining a cash balance above $425 million. The company posted a net loss of $30‑40 million, reflecting heightened R&D and integration expenses. It highlighted a $200 million plus business pipeline, including...
Kite Realty Group Reports Fourth Quarter and Full Year 2025 Operating Results and Provides 2026 Guidance
Kite Realty Group (KRG) posted a dramatic turnaround in 2025, reporting net income of $298.7 million ($1.37 per diluted share) versus $4.1 million the prior year. The REIT leased roughly 4.6 million sq ft at a 13.8% comparable cash‑leasing spread and entered two joint‑venture partnerships...
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Cogent Biosciences announced that its lead drug bezuclastinib is on track for multiple FDA submissions in 2026, including NDAs for non‑advanced systemic mastocytosis (Non‑AdvSM), advanced SM (AdvSM) and second‑line GIST. The company reported $901 million in cash, sufficient to fund operations...
Vicat - FY 2025 Results
Vicat reported FY 2025 organic sales up 3.3% year‑on‑year, accelerated to 8.1% in Q4, while EBITDA rose 3.7% LFL to €771 million with a stable 20% margin. Net debt fell €85 million, bringing leverage to 1.49 times, and free cash flow remained strong at...